Navigation Links
Predicine Establishes Dual CAP Accreditation for its Genomic Sequencing Laboratories in US and China to Support Global Clinical Trials
Date:10/18/2018

Predicine, a molecular insights company, announced today that its CLIA-certified genomic sequencing laboratory in the San Francisco Bay Area has received accreditation from the College of American Pathologists (CAP) for meeting the highest standards in quality, operations, and patient safety.

Predicine received CAP accreditation for its Shanghai facility last month. The current dual CAP accreditation of its laboratories in U.S and China enables the company to offer harmonized biomarker assays to its biopharma partners to support clinical trials in China and worldwide. In this setting, all patient samples collected in China will be locally processed in the Shanghai laboratory and samples collected outside of China will be shipped to and processed in the Hayward, California laboratory.

“The dual distinction of being CLIA-certified and CAP-accredited demonstrates our commitment to uphold the industry’s most stringent requirements in laboratory testing for our harmonized assays,” said Dr. Shidong Jia, Founder and CEO of Predicine. “Gaining identical CAP accreditation for both our Shanghai and Hayward facilities enables us to provide a unified quality management system to fully support our partners’ global clinical trials.”

Predicine has developed a propriety GeneRADAR liquid biopsy technology to detect genetic cancer variants in circulation using blood and urine samples. Most recently, Predicine launched an RUO 600-gene TMB liquid biopsy panel at AACR and partners with world-leading biopharmaceutical companies to support global clinical trials in U.S., Europe, Australia, and China.

About Predicine

Predicine is a molecular insights company that is committed to developing the best-in-class precision diagnostics and precision medicine portfolio to address the unmet medical needs worldwide. Predicine’s proprietary GeneRADAR technology is the industry’s first ctDNA+ctRNA combo liquid biopsy test to provide a comprehensive understanding of the molecular alterations in cancer. Through its integrated one-stop biomarker service facilities in US (California) and China (Shanghai, Harbin), Predicine partners with leading biopharma companies and hospitals to support global clinical trials, early cancer screening, and targeted therapy. For more, please visit predicine.com and follow Predicine on Twitter @Predicine.

Read the full story at https://www.prweb.com/releases/predicine_establishes_dual_cap_accreditation_for_its_genomic_sequencing_laboratories_in_us_and_china_to_support_global_clinical_trials/prweb15850777.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Predicine and Flagship Biosciences Partner to Support Global Biomarker Development
2. The Center for Advancing Innovation Establishes Ambassador Program
3. Western IRB Establishes Single-IRB Solution to Help Institutions Comply with New Mandate for NIH-Funded Research
4. Johnson & Johnson Establishes Susan Lindquist Chair for Women in Science
5. SenzaGen establishes subsidiary in the US
6. Global Pneumatic Tube System Provider Aerocom Establishes North American Office to Focus on Hospital Market
7. Evelo Therapeutics Establishes Core Executive Team
8. INSYS Group Establishes National Healthcare Practice
9. Ember Therapeutics Raises up to $6M and Establishes Commercial Partnership with Knight Therapeutics
10. ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma
11. Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2018)... (PRWEB) , ... October 30, 2018 , ... Pippa Rose is a young Labrador retriever. ... one year old, Pippa suffered a partial tear to the cruciate ligament in her right ... run or go on walks. Kinsley reported that it broke her heart to see ...
(Date:10/25/2018)... ... October 24, 2018 , ... To prepare for radiological and ... will work Argentum Medical, LLC to repurpose its commercial Silverlon ® ... technology, the privately held company has been awarded a three-year, $8.4 million contract with ...
(Date:10/24/2018)... ... October 23, 2018 , ... Molecular Devices LLC, a leader ... its recently created biologics solutions business unit. The business unit combines the industry-leading ... henceforth will be known as ForteBio. It is accompanied by a new logo. ...
(Date:10/17/2018)... ... October 17, 2018 , ... Dr. Richard Amato, founder of ... Kang, are offering current and new patients the opportunity to enjoy improved tooth ... proven treatment technology known as Piezosurgery® . As long-time believers in staying ...
Breaking Biology Technology:
(Date:11/13/2018)... ... November 13, 2018 , ... Fluence Bioengineering today unveiled ... VYPR 2 is well suited for sole-source and supplemental lighting applications addressing virtually ... , “As an all-purpose light which can be adapted to virtually any setting, ...
(Date:11/13/2018)... (PRWEB) , ... November 12, ... ... Triangle Park-based management consulting firm specializing in the life sciences, healthcare, and ... lead for Cybersecurity and Compliance. Summerville will be responsible for overseeing CREO’s ...
(Date:11/13/2018)... Calif. (PRWEB) , ... November 12, 2018 , ... Board-certified ... Grove, is welcoming individuals with multiple missing teeth in Santa Ana, CA and surrounding ... just one day. Using decades of experience, Dr. Kim regularly helps patients get the ...
Breaking Biology News(10 mins):